Sector
PharmaceuticalsOpen
₹16.61Prev. Close
₹16.61Turnover(Lac.)
₹0.53Day's High
₹17.44Day's Low
₹15.7852 Week's High
₹17.5552 Week's Low
₹7.22Book Value
₹8.12Face Value
₹10Mkt Cap (₹ Cr.)
23.13P/E
263.17EPS
0.06Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 4.88 | 4.88 | 4.88 | 4.88 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -5.72 | -5.76 | -5.77 | -5.66 |
Net Worth | -0.84 | -0.88 | -0.89 | -0.78 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 0.01 | 0 | 0 | 1.56 |
yoy growth (%) | 0 | 0 | -100 | 9,330.96 |
Raw materials | 0 | 0 | 0 | -1.5 |
As % of sales | 77.22 | 0 | 0 | 96.22 |
Employee costs | 0 | -0.01 | -0.02 | -0.03 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -0.1 | 0 | -0.01 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 6.4 |
Working capital | 0 | -0.01 | 0.01 | 0.01 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | -100 | 9,330.96 |
Op profit growth | 457.54 | -70.39 | -791.1 | 1,587.44 |
EBIT growth | 1,944.45 | -69.78 | -271.28 | 1,587.44 |
Net profit growth | 1,944.45 | -69.78 | -270.19 | -99.56 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,665.2 | 130.91 | 3,99,537.26 | 867.6 | 0.81 | 5,536.99 | 98.75 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,205.6 | 35.29 | 1,21,311.57 | 1,405.2 | 0.25 | 3,172.6 | 156.19 |
Cipla Ltd CIPLA | 1,499.9 | 32.61 | 1,21,119.62 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Divis Laboratories Ltd DIVISLAB | 4,549.75 | 76.67 | 1,20,781.57 | 531 | 0.66 | 2,259 | 507.93 |
Dr Reddys Laboratories Ltd DRREDDY | 6,854.2 | 26.69 | 1,14,348.41 | 1,034.8 | 0.58 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director & CFO
Murli Shivshankaran Nair
Non Executive Director
Reena Mahatma
Independent Director
Narayansinh Padudansinh Chauhan
Independent Director
Gautam Keshavlal Chauhan
Company Sec. & Compli. Officer
Manmeetkaur Harshdeepsingh Bhatia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Gujarat Inject (Kerala) Ltd
Summary
Gujarat Inject Kerala Limited was incorporated in Jan. 91. In 2004-05, Company started production of I.V. FIuids in April, 2005.
Read More
The Gujarat Inject (Kerala) Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹15.79 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Inject (Kerala) Ltd is ₹23.13 Cr. as of 22 Jul ‘24
The PE and PB ratios of Gujarat Inject (Kerala) Ltd is 263.17 and 1.94 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Gujarat Inject (Kerala) Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Gujarat Inject (Kerala) Ltd is ₹7.22 and ₹17.55 as of 22 Jul ‘24
Gujarat Inject (Kerala) Ltd's CAGR for 5 Years at N/I%, 3 Years at 86.61%, 1 Year at 114.25%, 6 Month at 0.19%, 3 Month at 16.88% and 1 Month at -0.82%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.